• Organizations: Pantheon Vision
Pantheon Vision and Eyedeal Medical to develop bioengineered corneal implant
Business

Pantheon Vision and Eyedeal Medical to develop bioengineered corneal implant

Collaboration involves advancement and commercialization of Pantheon’s artificial cornea as the company nears a potential premarket approval submission.
Pantheon Vision reports positive pre-clinical FDA meeting on bioengineered corneal implants
Pipeline

Pantheon Vision reports positive pre-clinical FDA meeting on bioengineered corneal implants

This marks the third-presubmission meeting as the company advances clinical development of a potential alternative to corneal transplants.
Pantheon Vision closes on $1.8M to advance bioengineered corneal implants
Pipeline

Pantheon Vision closes on $1.8M to advance bioengineered corneal implants

Company’s total funding adds up to over $4 million as it seeks to eliminate corneal blindness by reducing the global reliance on donated corneal tissues.
Pantheon Vision raises $2.5M to develop bioengineered corneal implant
Business

Pantheon Vision raises $2.5M to develop bioengineered corneal implant

Medical ophthalmic device company aims to reduce global reliance on donated corneal tissues.